# Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer

> **NCT02229058** · PHASE2 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 73 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Albumin Bound Paclitaxel
- **DRUG:** S-1

## Key facts

- **NCT ID:** NCT02229058
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2017-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02229058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02229058, "Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02229058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*